Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice

• Main Authors: Aqian Li (Author), Xinxian Dai (Author), Lei Chen (Author), Lin Liu (Author), Chuan Li (Author), Yang Liu (Author), Wei Wu (Author), Xiaoxia Huang (Author), Jiandong Li (Author), Shiwen Wang (Author), Mifang Liang (Author), Xiuling Li (Author), Dexin Li (Author)
• Format: Book
• Published: Elsevier, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Severe fever with thrombocytopenia syndrome (SFTS), caused by a novel identified bunyavirus SFTS virus (SFTSV), was an emerging viral infectious disease that was firstly reported in China. There are no licensed vaccines and therapeutics against SFTSV currently. B-Propiolactone (BPL) inactivated whol...